"Swine flu starting to show resistance to drugs" -- Oink oink Alert !!

---

* Reduced sensitivity seen to Roche's Tamiflu, GSK's Relenza

* Affects 30 pct Northern Australia samples, 10 pct from Singapore


10 June 2011

A novel variant of swine flu has emerged in Asia with a genetic adaptation giving some resistance to Roche's Tamiflu and GlaxoSmithKline's Relenza, the two mainstay drugs used to tackle the disease.

Reference:

http://www.reuters.com/article/2011/06/10/flu-drugs-idUSLDE7590QO20110610


------------


POSTED 11 June 2011 @ 3:30 AM by:

David A. Palella
Founder
BIOSCIENCE VENTURES Inc.
“Global Corporate Development for Biopharmaceuticals since 1991”

San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog:  http://biobizdev.blogspot.com


& Group Founder:

Japan Biotech/Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Asia Business & Finance Roundup
http://www.linkedin.com/e/vgh/3132759/

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

San Diego Biofuels & Sustainable Chemicals Networking Group
http://www.linkedin.com/e/vgh/3891375/

X-tech Roundup(SM) - San Diego
http://www.linkedin.com/e/vgh/2836926


& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448


--------